bumetanide and tram 34
bumetanide has been researched along with tram 34 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Adragna, NC; Chimote, AA; Lauf, PK; Misri, S | 1 |
| Cohen, M; Glaser, N; Little, C; Lo, W; O'Donnell, M; Tancredi, D; Wulff, H | 1 |
Other Studies
2 other study(ies) available for bumetanide and tram 34
| Article | Year |
|---|---|
Apparent intermediate K conductance channel hyposmotic activation in human lens epithelial cells.
Topics: Acetates; Blotting, Western; Bumetanide; Cell Line; Cell Membrane Permeability; Cell Size; Chloride Channels; Clotrimazole; Cyclopentanes; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Immunohistochemistry; Indans; Indenes; Intermediate-Conductance Calcium-Activated Potassium Channels; Ion Channel Gating; K Cl- Cotransporters; Kinetics; Lens, Crystalline; Niflumic Acid; Nitrobenzoates; Osmosis; Ouabain; Phloretin; Potassium; Potassium Channel Blockers; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; Rubidium; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase; Spectrophotometry, Atomic; Symporters; Voltage-Dependent Anion Channels | 2008 |
Treatment with the KCa3.1 inhibitor TRAM-34 during diabetic ketoacidosis reduces inflammatory changes in the brain.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Brain; Bumetanide; CD11b Antigen; Cerebral Cortex; Corpus Striatum; Diabetic Ketoacidosis; Encephalitis; Female; Glial Fibrillary Acidic Protein; Gliosis; Hippocampus; Male; Microglia; Nerve Tissue Proteins; Potassium Channel Blockers; Pyrazoles; Random Allocation; Small-Conductance Calcium-Activated Potassium Channels; Sodium Potassium Chloride Symporter Inhibitors | 2017 |